Original ArticleInternational Journal of Pharmaceutical InvestigationVol. 16 | Issue 1 | 2026 | pp. 324–329Open access
Formulation and Evaluation of Escitalopram Oxalate Oral Films by 32 Factorial Design
- 1,
- 1,
- 2*,
- 1,
- 1,
- 1,
- 1,
- 1,
- 1,
- 3
- 1 Department of Pharmaceutics, K.V.S.R. Siddhartha College of Pharmaceutical Sciences, Vijayawada, Krishna, Andhra Pradesh, INDIA.
- 2 Department of Pharmacology, V.V. Institute of Pharmaceutical Sciences, Gudlavalleru, Krishna, Andhra Pradesh, INDIA.
- 3 Department of Pharmaceutical Analysis, K.V.S.R. Siddhartha College of Pharmaceutical Sciences, Vijayawada, Krishna, Andhra Pradesh, INDIA.
Published in International Journal of Pharmaceutical Investigation
Correspondence: Shaik Aminabee
Department of Pharmacology, V.V. Institute of Pharmaceutical Sciences, Gudlavalleru, Krishna, Andhra Pradesh, INDIA.
Email: aminaammi786@gmail.com
Copyright: © 2026 Manuscript Technomedia. This is an open access article.
- Published:
- Jan 1, 2026
- Received:
- Apr 11, 2025
- Accepted:
- Aug 6, 2025
- DOI:
- 10.5530/ijpi.20260478
How to cite
Reddy, G. R., Shankar, K. R., Aminabee, S., Anusha, R., Nagaraja, K. V., Haindavi, B., Ramitunnisa, S., Babu, R. S., Eswar, P. S., & Jyothi, K. (2026). Formulation and Evaluation of Escitalopram Oxalate Oral Films by 32 Factorial Design. International Journal of Pharmaceutical Investigation, 16(1), 324–329. https://doi.org/10.5530/ijpi.20260478
Abstract
Background
The aim of this work was to develop a mouth dissolving film containing Escitalopram oxalate, utilizing basic ingredients such as polymers, plasticizers, sweeteners, saliva-stimulating agents, and flavors, to achieve rapid drug release with good mechanical properties.
Materials and Methods
The films were prepared using the solvent casting method. Hydroxy Propyl Methyl Cellulose (HPMC) E5 cps was used as the polymer to provide uniform film thickness, while propylene glycol was employed as a plasticizer to enhance folding endurance, tensile strength, and percent elongation. A 3² Factorial Design was utilized to optimize the formulations and assess the influence of variables on film properties.
Results and Discussion
The optimized formulation (F7) exhibited excellent properties, including good mouth feel, folding endurance, and rapid disintegration. The disintegration time was as short as 20 sec, and 99% of the drug was released within 10 min. These results demonstrated the formulation's potential for immediate drug delivery. Mouth dissolving films of Escitalopram oxalate were successfully developed using HPMC E5 cps and primojel.
Conclusion
The optimized Formulation (F7) showed promising attributes, such as rapid drug release, satisfactory mechanical properties, and a short disintegration time, making it a suitable candidate for pharmaceutical applications requiring a rapid onset of action.
Keywords
Subject
Article metadata
| Title | Formulation and Evaluation of Escitalopram Oxalate Oral Films by 32 Factorial Design |
|---|---|
| Authors | Gangireddy Ramana Reddy; Kunderu Ravi Shankar; Shaik Aminabee; Ravulapati Anusha; Komanduri Venkata Nagaraja; Borra Haindavi; Shaik Ramitunnisa; Rayavarapu Sanjay Babu; Pothuri Srinivasa Eswar; Koppula Jyothi |
| Affiliations | Department of Pharmaceutics, K.V.S.R. Siddhartha College of Pharmaceutical Sciences, Vijayawada, Krishna, Andhra Pradesh, INDIA.; Department of Pharmacology, V.V. Institute of Pharmaceutical Sciences, Gudlavalleru, Krishna, Andhra Pradesh, INDIA.; Department of Pharmaceutical Analysis, K.V.S.R. Siddhartha College of Pharmaceutical Sciences, Vijayawada, Krishna, Andhra Pradesh, INDIA. |
| Corresponding author | aminaammi786@gmail.com |
| Journal | International Journal of Pharmaceutical Investigation |
| Volume / Issue | Vol. 16, Issue 1 (2026) |
Also in this issue
- Anti-Parkinson Drug Levodopa: It's Novel Delivery Systems, Preclinical and Clinical Studies: A Reviewpp. 1–11
- Shifting Regulatory Frameworks for Nanomedicine in the Evolution of Personalized Medicinepp. 12–22
- A Global Perspective on Navigating the Regulatory Landscape of Adaptive AI in Healthcare: Balancing Innovation and Patient Safetypp. 23–29
- Impact of Artificial Intelligence Assisted Drug Therapy Optimization on Drug Related Problems Amongst Older Adult Patients: A Systematic Reviewpp. 30–42
- The Empowerment of Drugs Inspectors Under the Drugs and Cosmetics Act, 1940-A Review of Implementation of Power of Arrest Conferred by Hon’ble Supreme Court of Indiapp. 43–50